Marea Therapeutics, Inc.
San Francisco, US · Founded 2021 · 2 known investors
Founders & leadership
MJ
Mark JoingExecutive
CG
Christine GarrettExecutive
JL
Josh LehrerExecutive
EW
Ethan WeissExecutive
CM
Caitlin MurrayExecutive
Board
JT
Jeff TongBoard director
AR
Aaron RoystonBoard director
MK
Maha KatabiBoard director
AB
Antoine BoulangerBoard director
CG
Chris GarabedianBoard director
JC
Jung ChoiBoard director
TL
Ted LoveBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$65.4M disclosed across 1 round · 2024
▶$65.4MraisedJun 2024 · 10 investors · BiotechnologyRule 506(b)
▶$65.4MraisedJun 2024 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark JoingExecutive Officer
- Jeff TongDirector
- Christine GarrettExecutive Officer
- Josh LehrerExecutive Officer, Director
- Ethan WeissExecutive Officer
- Aaron RoystonDirector
- Caitlin MurrayExecutive Officer
- Jung ChoiDirector
- Maha KatabiDirector
- Ted LoveDirector
- Antoine BoulangerDirector
- Chris GarabedianDirector
- Offering amount
- $160.4M
- Amount sold
- $65.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Marea Therapeutics, Inc.'s investors?
- Marea Therapeutics, Inc.'s investors include Sofinnova Ventures, venBio Partners.
- How much funding has Marea Therapeutics, Inc. raised?
- Marea Therapeutics, Inc. has disclosed $65.4M raised across 1 round.
- Where is Marea Therapeutics, Inc. headquartered?
- Marea Therapeutics, Inc. is headquartered in San Francisco, US.